Boston Scientific completes enrollment in heart failure trial (Pharmaceutical Business Review)

Boston Scientific has completed enrollment in the multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy, known as MADIT-CRT.

Comments are closed.